CorMedix Inc. (CRMD) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the Core Medics Inc. Second Quarter 2025 Financial Results Conference Call. All participants will be in listen-only mode. Should you need assistance, please email conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To draw your question, please press star then two. Please note this event is being recorded. Now I'll turn the conference over to Daniel Ferry, Managing Director of Lifestyle Advisors. Please go ahead. Good morning and welcome to the Core Medics Second Quarter 2025 Earnings and Corporate Update Conference Call. Leading the call today is Joe Sidisco, Chief Executive Officer of Core Medics. And he is joined by Dr. Matt Damon, Executive Vice President of CFO. In addition, Beth Zelnick-Kaufman, EVP and Chief Legal and Compliance Officer. Liz Hurlburt, EVP and Chief Clinical Strategy and Operations Officer. And Erin Mystery, EVP and Chief Commercial Officer are on the line and will be available during the Q&A session. Before we begin, I would like to remind everyone that during the call, management may make what are known as forward-looking statements within the meeting set forth in the Private Securities and Litigation Reform Act of 1995. These statements are statements other than statements of historical facts regarding management's expectations, beliefs, goals and plans about the company's prospects and future financial position. Actual results may differ materially from the estimates and projections on which these statements are based due to a variety of important factors, including the risks and uncertainties described in greater detail in Core Medics filings at the SEC, whi...